Sign in

    Luismario Higuera

    Senior Equity Research Associate at Citigroup Inc.

    Luismario Higuera is a Senior Equity Research Associate at Citigroup Inc., specializing in equity research with a focus on fundamental company analysis and sector coverage. Since joining Citi in October 2022, he has contributed to detailed research publications and investment recommendations, drawing on his experience as an Investment Banking Analyst at J.P. Morgan from June 2021 to October 2022 and previous roles as an analyst intern. Although metrics such as success rates or returns and exact company coverage are not publicly disclosed, Higuera's background spans across both research and investment banking, supporting his analytical rigor. He holds professional credentials consistent with analyst roles at major financial institutions, though specific securities licenses or FINRA registrations are not confirmed in public records.

    Luismario Higuera's questions to GoodRx Holdings (GDRX) leadership

    Luismario Higuera's questions to GoodRx Holdings (GDRX) leadership • Q4 2024

    Question

    Luismario Higuera from Citigroup Inc., on for Daniel Grosslight, asked about GoodRx's current work with GLP-1 manufacturers and how that relationship might evolve as supply constraints ease.

    Answer

    CEO Wendy Barnes explained that GoodRx is already partnering with GLP-1 manufacturers on their co-pay coupon programs, driving significant traffic. With payer coverage for these drugs tightening, she stated GoodRx is in active dialogue to secure a competitive point-of-sale cash price, viewing it as a matter of 'when, not if.' CFO Chris McGinnis added that these high-level discussions exemplify their strategy across the entire pharmacy ecosystem.

    Ask Fintool Equity Research AI